Company Filing History:
Years Active: 2015-2017
Title: Yen-Wei Li: Innovator in Pharmaceutical Chemistry
Introduction
Yen-Wei Li is a notable inventor based in Taoyuan, Taiwan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of methods for producing optically pure compounds. With a total of 2 patents to his name, his work has implications for both the pharmaceutical industry and the advancement of chemical synthesis techniques.
Latest Patents
Yen-Wei Li's latest patents include a method of producing optically pure N-substituted-3-methoxy propionic acid. This innovative process involves the use of a chiral amine in a solvent to obtain a diastereomeric salt. The method is represented by a specific formula, where R is selected from the group consisting of Calkyl, Calkoxy, and Caryloxy groups. Additionally, he has developed a process for preparing duloxetine hydrochloride using an optically active methylhydroxylaminopropanol compound as an intermediate. This invention aims to achieve higher yield and lower production costs for duloxetine hydrochloride.
Career Highlights
Yen-Wei Li is currently associated with Sci Pharmtech Inc., where he continues to innovate and contribute to the field of pharmaceutical research. His work is characterized by a focus on improving the efficiency and effectiveness of chemical processes.
Collaborations
Some of his notable coworkers include Bo-Fong Chen and Feng-Hsu Li, who collaborate with him on various projects within the company.
Conclusion
Yen-Wei Li's contributions to pharmaceutical chemistry through his innovative patents and collaborative efforts highlight his role as a key figure in advancing chemical synthesis methods. His work continues to impact the industry positively.